Folate (vitamin B9 in its natural form) and its synthetic counterpart folic acid are the leading players in the methyl cycle, one of the most important biochemical pathways in the body. This cycle governs the conversion of homocysteine into methionine, the synthesis of DNA and RNA, DNA methylation (epigenetic regulation) and the synthesis of neurotransmitters. Raised plasma homocysteine (hyperhomocysteinaemia) is a marker associated with cardiovascular and neurological risk, documented across numerous longitudinal cohorts. This article explains how folate, homocysteine and cell function connect, what the evidence says, when it is worth paying attention and what can be done about it through diet and targeted supplementation.
Folate (vitamin B9): the vitamin of the methyl cycle
Folate is the umbrella term for a family of chemically related compounds that together make up vitamin B9. It is an essential water-soluble vitamin: the body cannot synthesise it and has to obtain it from the diet or from food supplements. The active coenzyme form is 5-methyltetrahydrofolate (5-MTHF), also known as methylfolate, and this is the form that ultimately enters the biochemical reactions of the methyl cycle.
Folate has eight functions recognised at European level, among them "contributes to normal amino acid synthesis", "normal homocysteine metabolism", "normal psychological function", "normal formation of red blood cells", "normal functioning of the immune system", "the reduction of tiredness and fatigue", "the process of cell division" and "normal maternal tissue growth during pregnancy". For a closer look at the nutrient on its own, see the Folic acid (vitamin B9) fact sheet.
The methyl cycle explained step by step
The methyl cycle is a cyclical biochemical sequence that keeps methyl groups (CH₃) flowing through the body. These methyl groups are critical to more than 200 enzymatic reactions, including DNA methylation (epigenetic regulation), the synthesis of neurotransmitters, the synthesis of membrane phospholipids and the production of muscle creatine.
The simplified sequence is:
- Methionine (an essential amino acid obtained from the diet) is converted into S-adenosylmethionine (SAMe), the body's universal methyl group donor.
- SAMe hands its methyl group over to multiple substrates (DNA, neurotransmitters, phospholipids) and becomes S-adenosylhomocysteine (SAH).
- SAH is hydrolysed into homocysteine, an intermediate amino acid.
- Homocysteine has two possible fates: (a) remethylation back to methionine, using methylfolate (5-MTHF) as the methyl donor and vitamin B12 as a cofactor for the enzyme methionine synthase, or (b) entering the transsulfuration pathway to synthesise cysteine, using vitamin B6 (pyridoxal-5-phosphate) as a cofactor.
If any of the three vitamins (B9, B12, B6) is deficient, the cycle slows down and homocysteine builds up in plasma — which shows up in a blood test as hyperhomocysteinaemia.
Homocysteine as a marker of cell function
Plasma homocysteine is a useful biomarker in clinical practice for several reasons:
- It reflects how well the methyl cycle is working: a normal homocysteine level indicates that the three vitamins (B9, B12, B6) are being supplied in sufficient amounts and that the enzymes are working properly.
- It is modifiable: unlike some fixed genetic biomarkers, homocysteine responds to targeted supplementation with folate + B12 + B6.
- It has a documented association with cardiovascular risk: the review by Tinelli and colleagues published in Frontiers in Nutrition in 2019 brings together the evidence on hyperhomocysteinaemia as a modifiable risk factor for cardiovascular and neurodegenerative disease.
An important point: the homocysteine-cardiovascular risk association is epidemiological and bidirectional. Lowering homocysteine with supplementation does NOT translate directly into lower individual cardiovascular risk across every profile — the large clinical trials on the question produced mixed results. The honest clinical reading is that homocysteine is a useful marker that tells us something about the methyl cycle, but NOT an absolute therapeutic target in healthy people without other risk factors.
Causes and consequences of hyperhomocysteinaemia
The most common causes of raised plasma homocysteine in clinical practice are:
- Folate (B9) deficiency: the most common cause in the general population. Particularly in people whose diet is low in leafy green vegetables and pulses.
- Vitamin B12 deficiency: especially prevalent in vegetarians and vegans who do not supplement, in older people with absorption problems, and in patients on long-term treatment with metformin or proton pump inhibitors.
- Vitamin B6 deficiency: less common, but relevant in chronic alcohol dependence and in some digestive conditions.
- Genetic polymorphisms in the MTHFR gene: the C677T and A1298C variants of methylenetetrahydrofolate reductase reduce the conversion of synthetic folic acid into active methylfolate. People who are homozygous for C677T (the TT genotype, ~10-15% of the general population) have a greater tendency towards hyperhomocysteinaemia and may benefit from taking methylfolate (5-MTHF) directly rather than synthetic folic acid.
- Renal insufficiency: the kidney is the main route by which homocysteine is cleared.
- Hypothyroidism: a shortfall of thyroid hormone raises homocysteine indirectly.
- Older age and smoking: well-established risk factors.
Natural folate, folic acid and methylfolate: what changes
In supplementation, folate is sold in three main forms with distinct biochemical profiles:
- Natural folate: the polyglutamate form found in food (leafy green vegetables, pulses, liver). It is hydrolysed to the monoglutamate form in the gut and then reduced to tetrahydrofolate.
- Synthetic folic acid: the fully oxidised form used in food supplements and fortified foods. It is the form most studied in clinical research historically, and the most stable. It requires enzymatic reduction in the liver to dihydrofolate → tetrahydrofolate → 5-MTHF before the body can use it.
- Methylfolate (5-MTHF): the directly active coenzyme form, which needs no conversion in the liver. Also available as a supplement. Particularly useful in people with MTHFR polymorphisms that reduce how efficiently synthetic folic acid is converted.
The B9 + B6 + B12 trio: why they work together
All three are needed to keep the methyl cycle running:
- Folate (B9): supplies the methyl group via 5-MTHF.
- Vitamin B12 (cobalamin): an obligatory cofactor for the enzyme methionine synthase, which transfers the methyl group from 5-MTHF to homocysteine. Without B12 the cycle stalls and the "folate trap" appears — folate accumulates as 5-MTHF that cannot be used. For a closer look, see the Vitamin B12 fact sheet.
- Vitamin B6 (pyridoxine): cofactor for the alternative transsulfuration pathway, where homocysteine is converted into cysteine. B6 diverts homocysteine away from the remethylation route when there is an excess.
The practical consequence is that supplementing with folate alone when there is a hidden B12 deficiency can be problematic: folate corrects the macrocytosis (the enlarged red blood cells typical of B12 deficiency) without correcting the underlying deficiency, delaying the diagnosis of a potentially serious neurological picture. For this reason, because of the risk of masking a B12 deficiency, public health guidance advises caution with folic acid taken without B12, and B-complex supplements usually include all three vitamins together.
When to measure homocysteine and when to supplement
Measuring plasma homocysteine as part of routine blood work is not indicated in the healthy general population without other risk factors. It is considered in specific profiles:
- Patients with early-onset cardiovascular disease or a strong family history.
- Patients with unexplained thrombotic events.
- Patients with clinical suspicion of B12 or folate deficiency.
- Women with unexplained recurrent miscarriage (as part of a specific work-up).
- Patients with hypothyroidism, renal insufficiency or diabetes.
Targeted supplementation with B9 + B12 + B6 is reasonable when there is:
- Documented hyperhomocysteinaemia (homocysteine >15 µmol/L under the usual criteria).
- A documented deficiency of any of the three vitamins on blood testing.
- Restrictive dietary patterns (vegetarian, vegan) in which B12 is always essential.
- Women of childbearing age planning a pregnancy (official public health recommendation: 400 µg/day of folic acid from before conception).
- Documented MTHFR polymorphisms with raised homocysteine (direct methylfolate preferred).
Specific contexts: preconception, older adults, MTHFR polymorphisms
Preconception and pregnancy
The official European public health recommendation is to start supplementing with 400 µg/day of folic acid at least one month before conception and to continue through the first trimester of pregnancy. It is officially recognised at European level that low maternal folate status is a risk factor in the development of neural tube defects (spina bifida, anencephaly), and that supplemental folic acid intake increases maternal folate status (conditions of use: 400 µg/day from before conception). In higher-risk contexts (a previous neural tube defect, maternal diabetes, treatment with antiepileptic medication), doses may rise to 4,000-5,000 µg/day under supervision.
Adults over 60-65
With age, gastric absorption of B12 declines because of the gastric atrophy that becomes common and the fall in intrinsic factor. Oral or sublingual B12 supplementation (50-1,000 µg/day depending on the context) is reasonable in people over 65, particularly if they take metformin or proton pump inhibitors (which also reduce absorption).
MTHFR polymorphisms
The C677T and A1298C variants of the MTHFR gene reduce the enzymatic activity of methylenetetrahydrofolate reductase, the enzyme that converts synthetic folic acid into active methylfolate. People who are TT homozygous for C677T (~10-15% of the general population) may convert it less efficiently and, in some cases, benefit from taking methylfolate (5-MTHF) directly rather than synthetic folic acid. That said, the debate over how clinically relevant these variants are in people without symptoms remains open, and MTHFR genetic testing in the general population is not supported by current clinical guidelines.
Folate in the Pleniage portfolio
Folic acid (vitamin B9) is part of Pro Calm+, together with KSM-66 ashwagandha, magnesium bisglycinate (Albion), L-theanine, rhodiola and vitamins B6 and B12. Aimed at the calm and nervous system profile.
Each ingredient has its own individual scientific research; the specific combinations used in the formulas have not been the subject of a clinical trial of their own.
This page is part of the Calm and Balance cluster. For a closer look at the wider biochemical context of the methyl cycle and energy metabolism, see the article Cellular energy and mitochondrial metabolism.
Folate (vitamin B9) is the central vitamin of the methyl cycle, alongside B12 and B6. Plasma homocysteine is a useful biomarker of how well that cycle is working and has a documented association with cardiovascular risk, although lowering it through supplementation does not automatically translate into lower individual risk. Supplementation with the B9 + B12 + B6 trio has a clear indication in specific contexts (preconception, vegetarian and vegan diets, adults over 60-65 with absorption problems, documented MTHFR polymorphisms with raised homocysteine), but it is not a universal recommendation for the healthy general population without a documented deficiency.
At PLENIAGE® we publish scientific content on evidence-based supplementation. You can explore the Calm and Balance cluster for more fact sheets and related articles.
References
The statements in this article are based on the available scientific literature and on the functions recognised at European level for folate (vitamin B9) and vitamins B12 and B6.
- European register of recognised functions — folate (vitamin B9): recognised functions covering normal amino acid synthesis, normal formation of red blood cells, normal homocysteine metabolism, normal psychological function, normal functioning of the immune system, the reduction of tiredness and fatigue, the process of cell division and normal maternal tissue growth during pregnancy; and a European recognition regarding the reduction of a risk factor (Art.14): low maternal folate status is a risk factor in the development of neural tube defects, and supplemental folic acid intake increases maternal folate status. Official source: official European Commission register of recognised nutrient functions.
- Tinelli C, Di Pino A, Ficulle E, Marcelli S, Feligioni M. Hyperhomocysteinemia as a Risk Factor and Potential Nutraceutical Target for Certain Pathologies. Front Nutr. 2019;6:49. PMID: 31069230.
- Bailey LB, Stover PJ, McNulty H, et al. Biomarkers of Nutrition for Development—Folate Review. J Nutr. 2015;145(7):1636S-1680S. PMID: 26451605.
Frequently asked questions (FAQ)
Do I need to have my homocysteine measured routinely?
No. In the healthy general population, without cardiovascular or thrombotic risk factors, homocysteine is not a routine measurement. It is indicated when there is early-onset cardiovascular disease or a strong family history, unexplained thrombotic events, clinical suspicion of B12 or folate deficiency, unexplained recurrent miscarriage, or certain conditions (hypothyroidism, renal insufficiency, diabetes). Ordering it on your own initiative, without clinical context, adds little useful information.
What is the difference between folate, folic acid and methylfolate?
Folate is the generic term for vitamin B9 in the natural forms found in food. Folic acid is the stable synthetic form used in supplements and fortified foods — the form most studied historically. Methylfolate (5-MTHF) is the directly active coenzyme form the body uses in the methyl cycle, with no need for conversion in the liver. All three forms converge on the same active form, but methylfolate may be preferable in people with documented MTHFR polymorphisms.
Why are folate and B12 supplemented together?
Because both are needed for the methyl cycle to work, and supplementing with folate alone when there is a hidden B12 deficiency can be problematic. Folate corrects the macrocytosis (enlarged red blood cells) without correcting the underlying B12 deficiency, delaying the diagnosis of a potentially serious neurological picture. For this reason, because of the risk of masking a B12 deficiency, public health guidance advises caution with folic acid taken without B12, and B-complex supplements usually include all three vitamins together (B9 + B12 + B6).
What is the relationship between homocysteine and heart attack risk?
Honestly: the association between raised homocysteine and cardiovascular risk is epidemiological and bidirectional. The large clinical trials of B9 + B12 + B6 supplementation to lower homocysteine in patients with cardiovascular disease produced mixed results — a consistent reduction in homocysteine but a modest impact on hard cardiovascular events. The honest reading is that homocysteine is a useful marker that tells us something about the methyl cycle, but NOT an absolute therapeutic target. Whether supplementation is indicated is assessed individually with your doctor.
How much folic acid do I need if I am planning a pregnancy?
The official European public health recommendation is 400 µg/day of folic acid, started at least one month before conception and continued through the first trimester of pregnancy. A supplemental intake of 400 µg/day of folic acid increases maternal folate status; low maternal folate status is a risk factor in the development of neural tube defects (spina bifida, anencephaly) — as officially recognised at European level. In higher-risk contexts (previous history, diabetes, antiepileptic medication), doses may rise to 4,000-5,000 µg/day under medical supervision. Talk to your doctor or gynaecologist to adjust this to your own profile.
Do I need to have an MTHFR genetic test?
Not routinely. MTHFR genetic testing in the asymptomatic general population is not supported by current clinical guidelines. The C677T and A1298C variants are common (up to 50% of the population carries at least one copy), but their clinical relevance in people without symptoms and with normal homocysteine is limited. The reasonable indications are: documented hyperhomocysteinaemia, unexplained recurrent miscarriage (as part of a specific work-up), or unexplained thrombotic events.
What role does folate play in psychological function?
Folate contributes to normal psychological function and takes part in the synthesis of neurotransmitters through the methyl cycle. A documented folate deficiency can be accompanied by changes in mood. Folate is not a treatment for any disorder and does not replace medical care; if you have symptoms affecting your mood, speak to a healthcare professional.